Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

How switching from brand name drugs to generics is sometimes absurd

Paul Sax, MD
Meds
June 16, 2011
Share
Tweet
Share

I had an interesting exchange with one of our nurses recently about a long-term patient of ours.

The e-mails went something like this:

Got a fax from —-’s insurance that his Lipitor won’t be covered anymore.  They will cover simvastatin, lovastatin, and pravastatin.  Let me know what you want to do.
Charlie

He’s on darunavir, and all three of those statins are contraindicated because of drug-drug interactions. Rosuvastatin?
Paul

Checked with them — rosuvastatin needs prior approval, and will cost him a lot more, but less than Lipitor. I’ll get the paperwork ready.
Charlie

An hour or so passes, and then this:

What dose rosuvastatin?
Charlie

5 mg daily, thanks.
Paul

Another hour, and then:

Just heard from them — after all the fuss, they approved the Lipitor after all.  Seems they just wanted to waste our time.
Charlie

Hysterical.

Look, I get it that generics are usually more cost-effective than branded drugs.  And I understand that health care costs are wildly out of control, and one way of controlling costs is to use generics whenever they are safe and effective, which is most of the time.

But think about the absurdity of the above case.

  1. The insurance company is paying for this man’s antiretroviral therapy, so they must know he’s on darunavir.
  2. They nonetheless are suggesting he switch to a contraindicated generic statin drug.
  3. They initially refuse to continue covering a drug that is working well and that the patient has been tolerating for years, but grudgingly will cover a slightly cheaper alternative.
  4. They set up barriers to jump over and tunnels to crawl through (the “prior approval” paperwork) even though there’s sound evidence to back up the requested brand-name treatments.
  5. After the obstacle course is navigated successfully by our experienced nurse, they relent and say that they’ll cover the original prescription after all.

And here’s the best part:  The exact same thing happened last year with this patient — with the same insurance company!

Reminds me of the classic Monty Python “Cheese Shop” sketch, where the customer (John Cleese) methodically asks cheese shop guy (Michael Palin) for dozens of different cheeses — all of them unavailable. When Cleese asks at the end if they have “any cheese at all,” here’s the response:

No, sir, not a scrap. I was deliberately wasting your time, sir.

ADVERTISEMENT

Paul Sax is the Clinical Director of Infectious Diseases at Brigham and Women’s Hospital. His blog HIV and ID Observations, is part of Journal Watch, where he is Editor of Journal Watch AIDS Clinical Care.

Submit a guest post and be heard on social media’s leading physician voice.

Prev

The accidental genius of homeopathy thrives

June 16, 2011 Kevin 37
…
Next

Docs vs Glocks, and the slippery slope of HB 155

June 16, 2011 Kevin 39
…

Tagged as: Medications, Specialist

Post navigation

< Previous Post
The accidental genius of homeopathy thrives
Next Post >
Docs vs Glocks, and the slippery slope of HB 155

ADVERTISEMENT

More by Paul Sax, MD

  • An infectious disease doctor answers your COVID-19 and coronavirus questions

    Paul Sax, MD
  • When should physicians read the House of God?

    Paul Sax, MD
  • Should we write that patients are “pleasant” in medical notes?

    Paul Sax, MD

More in Meds

  • Pharmacy benefit manager reform vs. direct drug plans

    Leah M. Howard, JD
  • A cautionary tale about pramipexole

    Anonymous
  • My persistent adverse reaction to an SSRI

    Scott McLean
  • Tofacitinib: a lesson in heart-immune health

    Larry Kaskel, MD
  • The case for regulating, not banning, kratom

    Heidi Sykora, DNP, RN
  • How India-Pakistan tensions could break America’s generic drug pipeline

    Adwait Chafale
  • Most Popular

  • Past Week

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Why CPT coding ambiguity harms doctors

      Muhamad Aly Rifai, MD | Physician
    • Reimagining medical education for the 21st century [PODCAST]

      The Podcast by KevinMD | Podcast
    • The collapse of developmental pediatrics

      Ronald L. Lindsay, MD | Physician
    • A pediatrician’s reckoning with behavior therapy

      Ronald L. Lindsay, MD | Physician
  • Past 6 Months

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The high cost of PCSK9 inhibitors like Repatha

      Larry Kaskel, MD | Conditions
    • A neurosurgeon’s fight with the state medical board [PODCAST]

      The Podcast by KevinMD | Podcast
  • Recent Posts

    • A question about maternal health and the rise in autism [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why early diagnosis of memory loss is crucial

      Scott Tzorfas, MD | Conditions
    • Rethinking stimulants for ADHD

      Carrie Friedman, NP | Conditions
    • Why young people need to care about bone health now

      Surgical Fitness Research Pod & Yoshihiro Katsuura, MD | Conditions
    • What burnout does to your executive function

      Seleipiri Akobo, MD, MPH, MBA | Physician
    • The paradox of primary care and value-based reform

      Troyen A. Brennan, MD, MPH | Policy

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 12 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Why CPT coding ambiguity harms doctors

      Muhamad Aly Rifai, MD | Physician
    • Reimagining medical education for the 21st century [PODCAST]

      The Podcast by KevinMD | Podcast
    • The collapse of developmental pediatrics

      Ronald L. Lindsay, MD | Physician
    • A pediatrician’s reckoning with behavior therapy

      Ronald L. Lindsay, MD | Physician
  • Past 6 Months

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The high cost of PCSK9 inhibitors like Repatha

      Larry Kaskel, MD | Conditions
    • A neurosurgeon’s fight with the state medical board [PODCAST]

      The Podcast by KevinMD | Podcast
  • Recent Posts

    • A question about maternal health and the rise in autism [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why early diagnosis of memory loss is crucial

      Scott Tzorfas, MD | Conditions
    • Rethinking stimulants for ADHD

      Carrie Friedman, NP | Conditions
    • Why young people need to care about bone health now

      Surgical Fitness Research Pod & Yoshihiro Katsuura, MD | Conditions
    • What burnout does to your executive function

      Seleipiri Akobo, MD, MPH, MBA | Physician
    • The paradox of primary care and value-based reform

      Troyen A. Brennan, MD, MPH | Policy

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

How switching from brand name drugs to generics is sometimes absurd
12 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...